Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience

Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience

Analia Rodriguez Garzotto,1 Oliver Heine,2 Matthew Turner,3 Francisco Rebollo Laserna,4 Andreas Lorenz5 1Hospital Universitario 12 de Octubre, Ctra Andalucía, Madrid, Spain; 2Zentralklinikum Suhl, Suhl, 3Sandoz International GmbH, Holzkirchen, Germany; 4Sandoz Farmaceutica SA, Madrid, Sp...

Full description

Bibliographic Details
Main Authors:	Rodriguez Garzotto A, Heine O, Turner M, Rebollo Laserna F, Lorenz A
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-04-01
Series:	Journal of Blood Medicine
Online Access:	http://www.dovepress.com/erythropoiesis-stimulating-agents-for-the-treatment-of-chemotherapy-in-a16598

Similar Items

Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience [Corrigendum]
by: Rodriguez Garzotto A, et al.
Published: (2014-07-01)

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
by: Patrick Biggar, et al.
Published: (2017-09-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents
by: Hikmat Abdel-Razeq, et al.
Published: (2020-09-01)

Preoperative Stimulation of Erythropoiesis in Patients with Anemia
by: V. I. Zagrekov, et al.
Published: (2010-04-01)

Erythropoiesis Stimulation in Patients with Postoperative Anemia
by: D. B. Borisov, et al.
Published: (2013-08-01)

End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
by: Shamia Hoque, et al.
Published: (2020-01-01)

Managing chemotherapy induced anemia with darbepoetin alfa and other erythropoiesis stimulating agents: a nurse's perspective
by: Derbyshire L, et al.
Published: (2013-11-01)

Are erythropoiesis-stimulating agents beneficial for anemia in chronic heart failure patients?
by: Diego Araneda, et al.
Published: (2016-12-01)

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients.
by: Kamalas Amnuay, et al.
Published: (2019-09-01)

Effects of erythropoiesis-stimulating agents on heart failure patients with anemia: a meta-analysis
by: Hengliang Zhang, et al.
Published: (2016-08-01)

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
by: Matti Aapro, et al.
Published: (2019-01-01)

Erythropoiesis stimulating agents approaches to modulate activity
by: Sinclair AM
Published: (2013-07-01)

Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer
by: Matti Aapro, et al.
Published: (2012-05-01)

Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial.
by: Valeria Saglimbene, et al.
Published: (2017-01-01)

Use of erythropoiesis-stimulating agents in obese hemodialysis patients
by: Sun-Hee Park
Published: (2018-09-01)

Timing-adjusted iron dosing enhances erythropoiesis-stimulating agent-induced erythropoiesis response and iron utilization
by: Tomoyuki Kawano, et al.
Published: (2017-05-01)

Assessment of Erythropoiesis-Stimulating Agents for Anemia Treatment among Chronic Kidney Disease Patients: A Descriptive, Retrospective Study
by: Zeinab Mohamed Elamin, et al.
Published: (2021-01-01)

Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
by: Tilman B. Drüeke
Published: (2018-11-01)

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?
by: Jay B. Wish
Published: (2020-09-01)

The impact of recently published negative erythropoiesis-stimulating agent studies on the clinical management of cancer-related anemia at a single center
by: Hikmat Abdel-Razeq, et al.
Published: (2010-04-01)

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
by: Hirokazu Honda, et al.
Published: (2016-01-01)

Chk1 haploinsufficiency results in anemia and defective erythropoiesis.
by: Nathan C Boles, et al.
Published: (2010-01-01)

A Budget Impact Analysis of the Introduction of Erythropoiesis Stimulating Agent Subsequent Entry Biologics for the Treatment of Anemia of Chronic Kidney Disease in Canada
by: Nicole W Tsao, et al.
Published: (2014-11-01)

Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policy
by: Cai, B., et al.
Published: (2021)

Anaemia and heart failure: is there still a role for erythropoiesis-stimulating agents?
by: Massimo Volpe, et al.
Published: (2017-04-01)

The Effect of Erythropoiesis-Stimulating Agents on Platelet Aggregation in Peritoneal Dialysis Patients
by: Serkan Bakırdöğen, et al.
Published: (2019-11-01)

Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients.
by: Marit M Suttorp, et al.
Published: (2013-01-01)

Erythropoietin, erythropoiesis, and malarial anemia : the mechanisms and implications of insufficient erythropoiesis during murine blood-stage malaria
by: Chang, Kai-Hsin, 1974-
Published: (2003)

A critical role for mTORC1 in erythropoiesis and anemia
by: Zachary A Knight, et al.
Published: (2014-09-01)

Resistance to Erythropoiesis-Stimulating Agents Is Associated with Arterial Microcalcification in Early Hemodialysis Patients
by: Hye Sung Won, et al.
Published: (2014-01-01)

Association of malnutrition-inflammation complex and responsiveness to erythropoiesis stimulating agents in hemodialysis patients
by: Manoch Rattanasompattikul, et al.
Published: (2012-06-01)

Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen
by: Bergur V. Stefánsson, et al.
Published: (2011-08-01)

Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma
by: Horváth-Puhó E, et al.
Published: (2018-09-01)

Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients
by: Koike K, et al.
Published: (2016-03-01)

Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy.
by: Carmel M McVicar, et al.
Published: (2010-07-01)

Implications of a Reduction in the Hemoglobin Target in Erythropoiesis-Stimulating Agent-Treated Hemodialysis Patients
by: Timothy V. Nguyen, et al.
Published: (2011-11-01)

Cannot write session to /tmp/vufind_sessions/sess_h6s8at7sqvnr6ds6uclkm4e9lr